Zilarvir (GPO)
1399
indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection

1399
indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection